FDA "Least Burdensome" Draft Guidance Unhelpful, Medical Alley Says
This article was originally published in The Gray Sheet
Executive Summary
FDA's recently released "least burdensome" draft guidance is not a useful tool for manufacturers seeking regulatory approvals, Medical Alley contends in comments submitted to the agency Nov. 23.